Could a postbiotic soothe irritable bowel syndrome?
NCT ID NCT07699926
First seen Jul 13, 2026 · Last updated Jul 15, 2026 · Updated 2 times
Summary
This study tests whether a daily postbiotic supplement called PosBion® can ease symptoms and improve quality of life in adults with irritable bowel syndrome (IBS). Participants take two sachets of the supplement each day for 12 weeks. Researchers measure changes in IBS symptoms, gut health, and related biomarkers using questionnaires and saliva samples.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- PosBion® (inactivated Lactobacillus plantarum RS5 and RI11)
- What this could lead to
- If it works, this could offer a natural, over-the-counter option to help manage IBS symptoms and improve gut health.
- What could go wrong
- This is a small, single-arm, open-label study with no placebo group, so results may be biased or not generalizable. The supplement may not work for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GUT HEALTH are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UCSI University
Cheras, Kuala Lumpur, 56000, Malaysia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Podcast vs. pamphlet: which boosts IBD knowledge best?
- Smartphone app aims to uncover food triggers for gut cancer survivors
- New oral drug for inflammatory bowel disease enters first human tests
- Could a new drug calm the gut and stop IBS pain?
- Double-Drug attack on stubborn IBD shows promise
- Gene test could end guesswork in IBD treatment